-transparent.png){kind=logo}
In monitoring the effects of industrial exposure resulting from the pharmaceutical manufacture of oestrogen-progestogen combinations by coagulation studies acceleration of some clotting tests was found. The most pronounced changes were in workers most closely associated with the industrial process. Less pronounced changes were found in women employees not closely concerned with the processing and may have been secondary to the postmenopausal bleeding to which they were prone. A safer work procedure elaborated by the Employment Medical Advisory Service was monitored by clotting studies for over a year but the three most highly exposed subjects showed no substantial improvement.
L Poller, and
J M Thomson, and
B W Otridge, and
K F Yee, and
S H Logan
August 1979,
British medical journal,
L Poller, and
J M Thomson, and
B W Otridge, and
K F Yee, and
S H Logan
May 1978,
British medical bulletin,
L Poller, and
J M Thomson, and
B W Otridge, and
K F Yee, and
S H Logan
April 1976,
Lijecnicki vjesnik,
L Poller, and
J M Thomson, and
B W Otridge, and
K F Yee, and
S H Logan
March 1982,
American journal of obstetrics and gynecology,
L Poller, and
J M Thomson, and
B W Otridge, and
K F Yee, and
S H Logan
September 1978,
Lijecnicki vjesnik,
L Poller, and
J M Thomson, and
B W Otridge, and
K F Yee, and
S H Logan
January 1967,
Clinical pharmacology and therapeutics,
L Poller, and
J M Thomson, and
B W Otridge, and
K F Yee, and
S H Logan
July 1985,
Obstetrical & gynecological survey,
L Poller, and
J M Thomson, and
B W Otridge, and
K F Yee, and
S H Logan
September 1973,
The Journal of nutrition,
L Poller, and
J M Thomson, and
B W Otridge, and
K F Yee, and
S H Logan
January 1968,
Acta endocrinologica,
L Poller, and
J M Thomson, and
B W Otridge, and
K F Yee, and
S H Logan
June 1986,
The Journal of reproductive medicine,
